The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis

References

• Abd El Hady WE, Soliman OAE-A, El Sabbagh HM, Mohamed EA. (2021). Glutaraldehyde-crosslinked chitosan–polyethylene oxide nanofibers as a potential gastroretentive delivery system of nizatidine for augmented gastroprotective activity. Drug Deliv 28:1795–809.
   PubMed Web of Science ®Google Scholar
• Abdel-Daim MM, Farouk SM, Madkour FF, Azab SS. (2015). Anti-inflammatory and immunomodulatory effects of Spirulina platensis in comparison to Dunaliella salina in acetic acid-induced rat experimental colitis. Immunopharmacol Immunotoxicol 37:126–39.
   PubMed Web of Science ®Google Scholar
• Abourehab MA, Khames A, Genedy S, et al. (2021). Sesame oil-based nanostructured lipid carriers of nicergoline, intranasal delivery system for brain targeting of synergistic cerebrovascular protection. Pharmaceutics 13:581.
   PubMed Web of Science ®Google Scholar
• Adakudugu EA, Ameyaw EO, Obese E, et al. (2020). Protective effect of bergapten in acetic acid-induced colitis in rats. Heliyon 6:e04710.
   PubMed Web of Science ®Google Scholar
• Andalib S, Varshosaz J, Hassanzadeh F, Sadeghi H. (2012). Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design. Adv Biomed Res 1:45.
   PubMedGoogle Scholar
• Anwer M, Ahmed MM, Aldawsari MF, et al. (2020). Eluxadoline loaded solid lipid nanoparticles for improved colon targeting in rat model of ulcerative colitis. Pharmaceuticals 13:255.
   Web of Science ®Google Scholar
• Appleyard CB, Wallace JL. (1995). Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269:G119–G25.
   PubMed Web of Science ®Google Scholar
• Ashkar A, Sosnik A, Davidovich-Pinhas M. (2022). Structured edible lipid-based particle systems for oral drug-delivery. Biotechnol Adv 54:107789.
   PubMed Web of Science ®Google Scholar
• Awaad AS, Alafeefy AM, Alasmary FA, et al. (2017). Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives. Saudi Pharm J 25:1125–9.
   PubMed Web of Science ®Google Scholar
• Baldo DEB, Serrano JE, Diomerl C, Baldo E. (2016). Screening for intestinal anti-inflammatory activity of Alpinia galanga against acetic acid-induced colitis in mice (Mus musculus). J Med Plants 4:72–7.
   Google Scholar
• Beloqui A, Solinís MÁ, Rodríguez-Gascón A, et al. (2016). Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine 12:143–61.
   PubMed Web of Science ®Google Scholar
• Boziki M, Grigoriadis N, Papaefthymiou A, et al. (2021). The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: a hypothesis. Neurochem Int 144:104938.
   PubMed Web of Science ®Google Scholar
• Can G, Ayvaz S, Can H, et al. (2015). The Syk inhibitor fostamatinib decreases the severity of colonic mucosal damage in a rodent model of colitis. J Crohns Colitis 9:907–17.
   PubMed Web of Science ®Google Scholar
• Chao J, Li Z, Liu Y, et al. (2016). Investigation of the inclusion interaction of p-sulfonatocalix [6] arene with trimebutine maleate. J Mol Liq 213:173–8.
   Web of Science ®Google Scholar
• Chevalier E, Pétoux F, Chovet M, Langlois A. (2004). Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats. Life Sci 76:319–29.
   PubMed Web of Science ®Google Scholar
• Cho KH, Choi YK, Kang JH, et al. (2010). Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia. Int J Pharm 400:145–52.
   PubMed Web of Science ®Google Scholar
• Courant T, Roullin V, Cadiou C, et al. (2009). Development and physicochemical characterization of copper complexes-loaded PLGA nanoparticles. Int J Pharm 379:226–34.
   PubMed Web of Science ®Google Scholar
• Duijvestein M, Wildenberg ME, Welling MM, et al. (2011). Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 29:1549–58.
   PubMed Web of Science ®Google Scholar
• El-Azab NE-E, Salem MY, El-Salam SA. (2016). A histological and immunohistochemical study of different therapeutic modalities for experimentally induced ulcerative colitis in rats. Egypt J Histol 39:12–24.
   Google Scholar
• El-Helw A-RM, Fahmy UA. (2015). Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers. Int J Nanomedicine 10:5797–804.
   PubMed Web of Science ®Google Scholar
• Emami J, Yousefian H, Sadeghi H. (2018). Targeted nanostructured lipid carrier for brain delivery of artemisinin: design, preparation, characterization, optimization and cell toxicity. J Pharm Pharm Sci 21:225s–41s.
   PubMed Web of Science ®Google Scholar
• Fisher ER, Anderson S, Dean S, et al. (2005). Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer 103:164–73.
   PubMed Web of Science ®Google Scholar
• Gao C, Yu S, Zhang X, et al. (2021). Dual functional Eudragit® S100/L30D-55 and PLGA colon-targeted nanoparticles of iridoid glycoside for improved treatment of induced ulcerative colitis. Int J Nanomedicine 16:1405–22.
   PubMed Web of Science ®Google Scholar
• Gao M, Zuou H, Zhu Y, Chen Y. (2017). Effect of trimebutine maleate tablets on serum TNF-α, IL-23, ESR, DD ulcerative colitis in patients with ulcerative colitis. Chin J Biochem Pharm 37:204–6.
   Google Scholar
• Garg NK, Tandel N, Bhadada SK, Tyagi RK. (2021). Nanostructured lipid carrier-mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases. Front Pharmacol 12:713616.
   PubMed Web of Science ®Google Scholar
• Gokce EH, Korkmaz E, Dellera E, et al. (2012). Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomedicine 7:1841–50.
   PubMed Web of Science ®Google Scholar
• Gu L, Sun R, Wang W, Xia Q. (2022). Nanostructured lipid carriers for the encapsulation of phloretin: preparation and in vitro characterization studies. Chem Phys Lipids 242:105150.
   PubMed Web of Science ®Google Scholar
• Hasan N, Imran M, Kesharwani P, et al. (2021). Intranasal delivery of naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose. Int J Pharm 599:120428.
   PubMed Web of Science ®Google Scholar
• Holmes E, Yong S, Eiznhamer D, Keshavarzian A. (1998). Glutathione content of colonic mucosa (evidence for oxidative damage in active ulcerative colitis). Dig Dis Sci 43:1088–95.
   PubMed Web of Science ®Google Scholar
• How CW, Abdullah R, Abbasalipourkabir R. (2011). Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80. Afr J Biotechnol 10:1684–9.
   Web of Science ®Google Scholar
• Hua S, Marks E, Schneider JJ, Keely S. (2015). Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine 11:1117–32.
   PubMed Web of Science ®Google Scholar
• Khosa A, Reddi S, Saha RN. (2018). Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother 103:598–613.
   PubMed Web of Science ®Google Scholar
• Kondamudi PK, Kovelamudi H, Mathew G, et al. (2014). Investigation of sesamol on myeloperoxidase and colon morphology in acetic acid-induced inflammatory bowel disorder in albino rats. Sci World J 2014:802701.
   Google Scholar
• Kotakadi VS, Jin Y, Hofseth AB, et al. (2008). Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis 29:1799–806.
   PubMed Web of Science ®Google Scholar
• Kovacevic A, Savic S, Vuleta G, et al. (2011). Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm 406:163–72.
   PubMed Web of Science ®Google Scholar
• Long Y, Liu Y, Tong J, et al. (2010). Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome. Eur J Pharmacol 636:159–65.
   PubMed Web of Science ®Google Scholar
• Moghddam SMM, Ahad A, Aqil M, et al. (2017). Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box–Behnken design approach. Artif Cells Nanomed Biotechnol 45:617–24.
   PubMed Web of Science ®Google Scholar
• Muhindo D, Ashour EA, Almutairi M, et al. (2021). Continuous production of raloxifene hydrochloride loaded nanostructured lipid carriers using hot-melt extrusion technology. J Drug Deliv Sci Technol 65:102673.
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing S. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–8.
   PubMed Web of Science ®Google Scholar
• Nedelcu A, Mosteanu O, Pop T, et al. (2021). Recent advances in nanoparticle-mediated treatment of inflammatory bowel diseases. Appl Sci 11:438.
   Google Scholar
• Ortiz AC, Yañez O, Salas-Huenuleo E, Morales JO. (2021). Development of a nanostructured lipid carrier (NLC) by a low-energy method, comparison of release kinetics and molecular dynamics simulation. Pharmaceutics 13:531.
   PubMed Web of Science ®Google Scholar
• Owusu G, Obiri DD, Ainooson GK, et al. (2020). Acetic acid-induced ulcerative colitis in Sprague Dawley rats is suppressed by hydroethanolic extract of Cordia vignei leaves through reduced serum levels of TNF-α and IL-6. Int J Chronic Dis 2020:1–11.
   Google Scholar
• Patil GB, Patil ND, Deshmukh PK, et al. (2016). Nanostructured lipid carriers as a potential vehicle for carvedilol delivery: application of factorial design approach. Artif Cells Nanomed Biotechnol 44:12–9.
   PubMed Web of Science ®Google Scholar
• Pereira RR, Testi M, Rossi F, et al. (2019). Ucuùba (Virola surinamensis) fat-based nanostructured lipid carriers for nail drug delivery of ketoconazole: development and optimization using Box–Behnken design. Pharmaceutics 11:284.
   PubMed Web of Science ®Google Scholar
• Petkar KC, Chavhan S, Kunda N, et al. (2018). Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design. AAPS PharmSciTech 19:1758–72.
   PubMed Web of Science ®Google Scholar
• Qelliny MR, Aly UF, Elgarhy OH, Khaled KA. (2019). Budesonide-loaded Eudragit S 100 nanocapsules for the treatment of acetic acid-induced colitis in animal model. AAPS PharmSciTech 20:1–17.
   Web of Science ®Google Scholar
• Rahman HS, Rasedee A, How CW, et al. (2013). Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine 8:2769–81.
   PubMed Web of Science ®Google Scholar
• Rashidian A, Roohi P, Mehrzadi S, et al. (2016). Protective effect of Ocimum basilicum essential oil against acetic acid-induced colitis in rats. J Evid Based Complementary Altern Med 21:NP36–NP42.
   PubMedGoogle Scholar
• Rathbone M. (2011). Controlled release in oral drug delivery. In: Rathbone MJ, editor. New York, Dordrecht, Heidelberg, London: Springer.
   Google Scholar
• Sanad RA, AbdelMalak NS, Elbayoomy TS, Badawi AA. (2010). Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs). AAPS PharmSciTech 11:1684–94.
   PubMed Web of Science ®Google Scholar
• Schreiber O, Petersson J, Walden T, et al. (2013). iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats. PLoS One 8:e71843.
   PubMed Web of Science ®Google Scholar
• Shi F, Yang G, Ren J, et al. (2013). Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers. Int J Nanomedicine 8:2533–41.
   PubMed Web of Science ®Google Scholar
• Sinhmar GK, Shah NN, Chokshi NV, et al. (2018). Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease. Drug Dev Ind Pharm 44:1078–89.
   PubMed Web of Science ®Google Scholar
• Sut T N, Jackman JA, Yoon BK. (2019). Influence of NaCl concentration on bicelle-mediated SLB formation. Langmuir 35(32):10658–66.
   Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, et al. (2008). Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release 128:134–41.
   PubMed Web of Science ®Google Scholar
• Ukai H, Imanishi A, Kaneda A, et al. (2020). Absorption-enhancing mechanisms of Capryol 90, a novel absorption enhancer, for improving the intestinal absorption of poorly absorbed drugs: contributions to trans- or para-cellular pathways. Pharm Res 37:1–14.
   Web of Science ®Google Scholar
• Varela-Fernández R, García-Otero X, Díaz-Tomé V, et al. (2022). Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery. Eur J Pharm Biopharm 172:144–56.
   PubMed Web of Science ®Google Scholar
• Vieira R, Severino P, Nalone LA, et al. (2020). Sucupira oil-loaded nanostructured lipid carriers (NLC): lipid screening, factorial design, release profile, and cytotoxicity. Molecules 25:685.
   PubMed Web of Science ®Google Scholar
• Vitorino C, Almeida J, Gonçalves LM, et al. (2013). Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. J Control Release 167:301–14.
   PubMed Web of Science ®Google Scholar
• Vitorino C, Carvalho FA, Almeida AJ, et al. (2011). The size of solid lipid nanoparticles: an interpretation from experimental design. Colloids Surf B Biointerfaces 84:117–30.
   PubMed Web of Science ®Google Scholar
• Wangchuk P, Navarro S, Shepherd C, et al. (2015). Diterpenoid alkaloids of Aconitum laciniatum and mitigation of inflammation by 14-O-acetylneoline in a murine model of ulcerative colitis. Sci Rep 5:1–10.
   Web of Science ®Google Scholar
• Wu K-W, Sweeney C, Dudhipala N, et al. (2021). Primaquine loaded solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and nanoemulsion (NE): effect of lipid matrix and surfactant on drug entrapment, in vitro release, and ex vivo hemolysis. AAPS PharmSciTech 22:1–12.
   Web of Science ®Google Scholar